Project Improving Biotherapeutic Workflows Highlighted at BioProcess Conference
Complete the form below to unlock access to ALL audio articles.
Rentschler Biopharma SE, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, has announced its line-up of activities during the BioProcess International (BPI) Conference, being held during Biotech Week Boston in September.
The focus will be on its newest facility, located in greater Boston in Milford, MA, and the new projects taking place there, including multi-specific antibodies. The site will support both clinical and commercial manufacturing programs as the projects advance through development.
Dr. Jesús Zurdo, Senior Vice President Innovation and Venture Partnerships, added: “At Rentschler Biopharma, we are working to improve our processes and implement new technologies with the goal of enabling better, faster, more cost-effective development and production for our clients. The integration of the methodologies being presented at BPI with faster cell line development workflows and streamlined fit-for-purpose process development could dramatically transform overall biotherapeutic development timelines and increase bioprocessing efficiency.”
